Inside one of the biggest cannabis investor conferences thumbnail

Inside one of the biggest cannabis investor conferences

The cannabis buzz. Is regulation a catalyst for pot stocks? Is it time to buy? With FM trader Tim Seymour, CNBC’s Melissa Lee and the Fast Money traders, Dan Nathan,…

How midterm elections could impact the cannabis business thumbnail

How midterm elections could impact the cannabis business

Vivien Azer, Cowen senior research analyst, and CNBC’s Aditi Roy join ‘Squawk Alley’ to discuss how cannabis regulation could be affected by the midterm elections, specifically in Utah, North Dakota,…

Cannabis reclassification is 'a real milestone' for the industry," says Curaleaf's Boris Jordan thumbnail

Cannabis reclassification is ‘a real milestone’ for the industry,” says Curaleaf’s Boris Jordan

Boris Jordan, co-founder and executive chairman of Curaleaf, joins ‘Squawk on the Street’ to discuss the significance of cannabis’ reclassification, the federal tax code around cannabis, and much more.

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC thumbnail

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC

The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…

Firing up the cannabis trade thumbnail

Firing up the cannabis trade

Trader Tim Seymour on why he’s long a number of cannabis stocks. With CNBC’s Courtney Reagan and the Fast Money traders, Victoria Fernandez and Delano Saporu. For access to live…

The organization 'Smart Approaches to Marijuana' wants America to rethink legalizing cannabis thumbnail

The organization ‘Smart Approaches to Marijuana’ wants America to rethink legalizing cannabis

Kevin Sabet, president and CEO of Smart Approaches to Marijuana, an organization leading the lobbying effort against legalization of the drug, joins “Squawk Box” to explain why his organization is…

GW Pharma CEO on new cannabis-derived drug thumbnail

GW Pharma CEO on new cannabis-derived drug

GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says about the future of cannabis-derived drugs.

Aurora Cannabis CEO discusses outlook of cannabis industry thumbnail

Aurora Cannabis CEO discusses outlook of cannabis industry

Virginia is the latest state to approve adult-use marijuana legalization following New Jersey. Aurora Cannabis CEO Miguel Martin says he sees booming opportunity in the cannabis industry as more states…

There's 'exuberance' in markets, driving cannabis stock higher: Canaccord Genuity analyst thumbnail

There’s ‘exuberance’ in markets, driving cannabis stock higher: Canaccord Genuity analyst

Matt Bottomley from Canaccord Genuity says there’s a lot of exuberance coming into the market that may be moving the cannabis stock higher. He joins ‘Closing Bell’ to discuss his…

Trulieve CEO Kim Rivers on Q4 earnings and cannabis adult use ballot in the U.S. thumbnail

Trulieve CEO Kim Rivers on Q4 earnings and cannabis adult use ballot in the U.S.

Kim Rivers, Trulieve CEO, founder, and chairwoman, joins ‘Fast Money’ to talk quarterly results, cannabis on the ballot, consumer trends and more.